The objective of the Roswell Park Memorial Institute Core Center Grant is to develop shared resources that are central to overall program objectives of the Institute and contribute to activities of priority to a variety of disciplines. Roswell Park maintains a Core Grant Committee to review objectives of the core grant program, to monitor activities and accomplishments of core projects to date, and to identify future core activities for development. Individual investigators throughout the Institute are invited to nominate for core support suitable shared services that would provide a core resource for a broad representation of Institute activities. The four most meritorious proposals have been selected for inclusion in this renewal application. The Computer Science Methodology Unit develops computing, statistical, and systems management methodologies for the design, implementation, data collection, data entry and editing, retrieval, analysis, and evaluation of basic and clinical cancer research. The Animal Biocontainment Facility will provide supervisory personnel in a building renovated for chemical carcinogenesis studies and for athymic nude mouse and rat work. The Image Analysis section requests equipment and technical support to digitize, store, and analyze data generated from electron microscopy, autoradiography, chromosome and DNA spreads, cell sorting, two-dimensional gel electrophoresis, etc. The Medical Record Registry provides casefinding and reference data for detailed clinical research and epidemiological studies. The core grant also provides developmental funds to recently trained investigators working in promising fields which are underdeveloped within the center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016056-14S1
Application #
3101508
Study Section
Cancer Center Support Grant Review Committee (CCS)
Project Start
1983-12-01
Project End
1990-04-30
Budget Start
1987-12-01
Budget End
1990-04-30
Support Year
14
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Eng, Diana G; Kaverina, Natalya V; Schneider, Remington R S et al. (2018) Detection of renin lineage cell transdifferentiation to podocytes in the kidney glomerulus with dual lineage tracing. Kidney Int 93:1240-1246
Ling, Xiang; Wu, Wenjie; Fan, Chuandong et al. (2018) An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. J Exp Clin Cancer Res 37:240
Chung, Sejin; Vail, Paris J; Witkiewicz, Agnieszka K et al. (2018) Coordinately targeting cell cycle checkpoint functions in integrated models of pancreatic cancer. Clin Cancer Res :
Mohammadpour, Hemn; O'Neil, Rachel; Qiu, Jingxin et al. (2018) Blockade of Host ?2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs. J Immunol 200:2479-2488
Hsu, Alice H; Lum, Michelle A; Shim, Kang-Sup et al. (2018) Crosstalk between PKC? and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. Cell Rep 24:655-669
Sandlesh, Poorva; Juang, Thierry; Safina, Alfiya et al. (2018) Uncovering the fine print of the CreERT2-LoxP system while generating a conditional knockout mouse model of Ssrp1 gene. PLoS One 13:e0199785
Zhang, Dingxiao; Zhao, Shuhong; Li, Xinyun et al. (2018) Prostate Luminal Progenitor Cells in Development and Cancer. Trends Cancer 4:769-783
Hong, Chi-Chen; Sucheston-Campbell, Lara E; Liu, Song et al. (2018) Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium. Cancer Epidemiol Biomarkers Prev 27:321-330
Damayanti, Nur P; Budka, Justin A; Khella, Heba W Z et al. (2018) Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma. Clin Cancer Res 24:5977-5989
Mayor, Paul; Starbuck, Kristen; Zsiros, Emese (2018) Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies. Gynecol Oncol 150:361-369

Showing the most recent 10 out of 1555 publications